Tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity.
BRAND NAME:– Zena Plus
GENERIC NAME:-Tizanidine Hydrochloride USP , Tizanidine , Nimesulide BP
COMPOSITION:- Each Film Coated Tablet Contains:
Tizanidine Hydrochloride USP
eq. to Tizanidine ………………….. 2 mg
Nimesulide BP……………………100 mg
DOSAGE FORM:- Tizanidine tablets may be prescribed with or without food. Once the formulation has been selected and the decision to take with or without food has been made, this regimen should not be altered.
Food has complex effects on tizanidine pharmacokinetics, which differ with the different formulations. Tizanidine capsules and tizanidine tablets are bioequivalent to each other under fasting conditions (more than 3 hours after a meal), but not under fed conditions (within 30 minutes of a meal). These pharmacokinetic differences may result in clinically significant differences when switching administration of tablet and capsules and when switching administration between the fed or fasted state. These changes may result in increased adverse events, or delayed or more rapid onset of activity, depending upon the nature of the switch. For this reason, the prescriber should be thoroughly familiar with the changes in kinetics associated with these different conditions.
The recommended starting dose is 2 mg. Because the effect of tizanidine peaks at approximately 1 to 2 hours post-dose and dissipates between 3 to 6 hours post-dose, treatment can be repeated at 6 to 8 hour intervals, as needed, to a maximum of three doses in 24 hours.
Dosage can be gradually increased by 2 mg to 4 mg at each dose, with 1 to 4 days between dosage increases, until a satisfactory reduction of muscle tone is achieved. The total daily dose should not exceed 36 mg. Single doses greater than 16 mg have not been studied.
PACKAGING:-3 X 10 Tablets
Following Information is for the use only of a Registered Medical Practitioner or Hospital or a Laboratory or Healthcare Personnel only.
Tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important.
Treatment of acute pain.
Nimesulide should only be prescribed as secon